Sex Differences in Chronic Kidney Disease
An Exploratory Study in Three Parts to Determine Sex-Specific Differences in Chronic Kidney Disease Recognition, Progression and Treatment
1 other identifier
observational
1,100
1 country
1
Brief Summary
This study aims to describe sex specific differences of the hemodialysis population in Austria, to quantify sex specific differences in treatment and outcomes in hospitalized patients with chronic kidney disease and to examine decision making by doctors and patients with regards to hemodialysis initiation. To adequately serve the needs of these research questions, the study is divided into 3 parts (sub-studies).
- 1.Description and analysis of sex-specific differences in renal replacement therapy in Austria.
- 2.Description and analysis of the competing risks of death versus renal replacement therapy initiation in the chronic kidney disease population by sex.
- 3.Analysis of sex differences in renal replacement therapy initiation decisions, emphasizing patient perception and socio-economic differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2018
CompletedStudy Start
First participant enrolled
December 2, 2018
CompletedFirst Posted
Study publicly available on registry
December 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedOctober 24, 2023
October 1, 2023
5.2 years
December 2, 2018
October 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Sex-specific mortality among incident patients undergoing hemodialysis
"Incident" hemodialysis patients are all those who have entered the Dialysis Registry (they will constitute the study population).
Through study completion, the expected average follow-up being 4 years.
Eligibility Criteria
as specified in the detailed study description
You may qualify if:
- Austrian Dialysis Registry Patient or outpatient
- Criteria for participation in the survey will be (i) a diagnosis of CKD (eGFR \<60 mL/min/1.73 m2) \[50% \<15\]) and (ii) appropriate language skills to fill in a survey.
You may not qualify if:
- Not an Austrian Dialysis Registry Patient or not an outpatient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assoc. Prof. Dr. Manfred Hecking, MD PhDlead
- Karolinska Institutetcollaborator
Study Sites (1)
Medical University of Vienna
Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rainer Oberbauer, MD
Medical University of Vienna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 2, 2018
First Posted
December 11, 2018
Study Start
December 2, 2018
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
October 24, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share